Salivary diagnostics platform using mass spectrometry for non-invasive testing
Biolyz operates a full-stack salivary diagnostics business built on LC-MS/MS infrastructure across Europe and the UK. The tech stack—LC-MS instruments, LIMS, AWS CDK, Datadog, and GitHub Actions—reflects a lab-ops-first approach: engineering is wiring together high-throughput sample processing, real-time data integration, and cloud observability rather than building consumer-facing software. Active hiring across engineering, research, and ops, with weighted seniority (6 senior roles), signals aggressive scaling of lab capacity and analytical method validation.
Notable leadership hires: Laboratory Head
Biolyz develops salivary-based diagnostic tests using liquid chromatography–mass spectrometry (LC-MS) to enable rapid, non-invasive prognostics at lower cost than traditional blood tests. The company operates physical lab infrastructure across Austria, Germany, and the United Kingdom, where it installs and maintains high-throughput SCIEX QTRAP systems. Core operational challenges center on 24/7 data integration from mass spectrometers, sample logistics, turnaround-time guarantees, and regulatory compliance. The business serves clinical and occupational health use cases including injury prevention, recovery optimization, and load management.
Biolyz uses LC-MS and LC-MS/MS instruments, LIMS for lab management, AWS (CDK, CloudFormation, CloudWatch), GitHub Actions for CI/CD, and Datadog for monitoring. The company is adopting Terraform for infrastructure-as-code.
Key pain points include 24/7 LC-MS data integration, high-throughput sample processing with rapid turnaround times, smooth logistics operations, inventory management, regulatory compliance, and reliable cloud infrastructure to handle variable workload spikes.
Other companies in the same industry, closest in size